Literature DB >> 33718295

Case Report: A Novel de novo Mutation in DNM1L Presenting With Developmental Delay, Ataxia, and Peripheral Neuropathy.

Yanping Wei1, Min Qian1.   

Abstract

DNM1L encodes dynamin-related protein 1 (Drp1), which is a member of the dynamin superfamily of GTPases and mediates mitochondrial and peroxisomal fission. In humans, several de novo heterozygous missense mutations in DNM1L have been reported, which were characterized by devastating courses with refractory epilepsy, myoclonus, and brain atrophy on MRI. We describe a 4.5-year-old male child harboring a novel de novo mutation in DNM1L presenting a phenotype of developmental delay, ataxia, and peripheral neuropathy. The clinical features, magnetic resonance imaging findings, and genetic results were summarized. Meanwhile, all the cases of DNM1L mutations reported were reviewed. DNM1L variants may need to be considered in phenotypes that include global developmental delay, peripheral neuropathy, and ataxia.
Copyright © 2021 Wei and Qian.

Entities:  

Keywords:  DNM1L; MRI; dynamin-related protein 1; mutation; peripheral neuropathy

Year:  2021        PMID: 33718295      PMCID: PMC7952519          DOI: 10.3389/fped.2021.604105

Source DB:  PubMed          Journal:  Front Pediatr        ISSN: 2296-2360            Impact factor:   3.418


  17 in total

Review 1.  Fusion and fission: interlinked processes critical for mitochondrial health.

Authors:  David C Chan
Journal:  Annu Rev Genet       Date:  2012-08-29       Impact factor: 16.830

Review 2.  De Novo DNM1L Variant in a Teenager With Progressive Paroxysmal Dystonia and Lethal Super-refractory Myoclonic Status Epilepticus.

Authors:  Conor S Ryan; Anthony L Fine; Alexander L Cohen; Brenda M Schiltz; Deborah L Renaud; Elaine C Wirrell; Marc C Patterson; Nicole J Boczek; Raymond Liu; Dusica Babovic-Vuksanovic; David C Chan; Eric T Payne
Journal:  J Child Neurol       Date:  2018-06-07       Impact factor: 1.987

3.  Structural insights into oligomerization and mitochondrial remodelling of dynamin 1-like protein.

Authors:  Chris Fröhlich; Stefan Grabiger; David Schwefel; Katja Faelber; Eva Rosenbaum; Jason Mears; Oliver Rocks; Oliver Daumke
Journal:  EMBO J       Date:  2013-04-12       Impact factor: 11.598

4.  Postnatal microcephaly and pain insensitivity due to a de novo heterozygous DNM1L mutation causing impaired mitochondrial fission and function.

Authors:  Ruth Sheffer; Liza Douiev; Simon Edvardson; Avraham Shaag; Khaled Tamimi; Devorah Soiferman; Vardiella Meiner; Ann Saada
Journal:  Am J Med Genet A       Date:  2016-03-17       Impact factor: 2.802

5.  A novel de novo dominant negative mutation in DNM1L impairs mitochondrial fission and presents as childhood epileptic encephalopathy.

Authors:  Jill A Fahrner; Raymond Liu; Michael Scott Perry; Jessica Klein; David C Chan
Journal:  Am J Med Genet A       Date:  2016-05-04       Impact factor: 2.802

6.  DNM1L-related mitochondrial fission defect presenting as refractory epilepsy.

Authors:  Jason R Vanstone; Amanda M Smith; Skye McBride; Turaya Naas; Martin Holcik; Ghadi Antoun; Mary-Ellen Harper; Jean Michaud; Erick Sell; Pranesh Chakraborty; Martine Tetreault; Jacek Majewski; Stephen Baird; Kym M Boycott; David A Dyment; Alex MacKenzie; Matthew A Lines
Journal:  Eur J Hum Genet       Date:  2015-11-25       Impact factor: 4.246

7.  Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission.

Authors:  Sylvie Gerber; Majida Charif; Jean-Michel Rozet; Guy Lenaers; Arnaud Chevrollier; Tanguy Chaumette; Claire Angebault; Mariame Selma Kane; Aurélien Paris; Jennifer Alban; Mélanie Quiles; Cécile Delettre; Dominique Bonneau; Vincent Procaccio; Patrizia Amati-Bonneau; Pascal Reynier; Stéphanie Leruez; Raphael Calmon; Nathalie Boddaert; Benoit Funalot; Marlène Rio; Didier Bouccara; Isabelle Meunier; Hiromi Sesaki; Josseline Kaplan; Christian P Hamel
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

8.  Lethal Disorder of Mitochondrial Fission Caused by Mutations in DNM1L.

Authors:  Grace Yoon; Zeenat Malam; Tara Paton; Christian R Marshall; Ella Hyatt; Zhenya Ivakine; Stephen W Scherer; Kyong-Soon Lee; Cynthia Hawkins; Ronald D Cohn
Journal:  J Pediatr       Date:  2016-01-26       Impact factor: 4.406

9.  De novo pathogenic DNM1L variant in a patient diagnosed with atypical hereditary sensory and autonomic neuropathy.

Authors:  Maja Tarailo-Graovac; Farah R Zahir; Irena Zivkovic; Michelle Moksa; Kathryn Selby; Sunita Sinha; Corey Nislow; Sylvia G Stockler-Ipsiroglu; Ruth Sheffer; Ann Saada-Reisch; Jan M Friedman; Clara D M van Karnebeek; Gabriella A Horvath
Journal:  Mol Genet Genomic Med       Date:  2019-09-01       Impact factor: 2.183

10.  Functional mapping of human dynamin-1-like GTPase domain based on x-ray structure analyses.

Authors:  Julia Wenger; Eva Klinglmayr; Chris Fröhlich; Clarissa Eibl; Ana Gimeno; Manuel Hessenberger; Sandra Puehringer; Oliver Daumke; Peter Goettig
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  3 in total

Review 1.  Genetic Neuropathy Due to Impairments in Mitochondrial Dynamics.

Authors:  Govinda Sharma; Gerald Pfeffer; Timothy E Shutt
Journal:  Biology (Basel)       Date:  2021-03-26

2.  Novel DNM1L variants impair mitochondrial dynamics through divergent mechanisms.

Authors:  Kelsey A Nolden; John M Egner; Jack J Collier; Oliver M Russell; Charlotte L Alston; Megan C Harwig; Michael E Widlansky; Souphatta Sasorith; Inês A Barbosa; Andrew Gl Douglas; Julia Baptista; Mark Walker; Deirdre E Donnelly; Andrew A Morris; Hui Jeen Tan; Manju A Kurian; Kathleen Gorman; Santosh Mordekar; Charu Deshpande; Rajib Samanta; Robert McFarland; R Blake Hill; Robert W Taylor; Monika Oláhová
Journal:  Life Sci Alliance       Date:  2022-08-01

3.  Case report: Thirty-year progression of an EMPF1 encephalopathy due to defective mitochondrial and peroxisomal fission caused by a novel de novo heterozygous DNM1L variant.

Authors:  Charlène Lhuissier; Bart E Wagner; Amy Vincent; Gaëtan Garraux; Olivier Hougrand; Rudy Van Coster; Valerie Benoit; Deniz Karadurmus; Guy Lenaers; Naïg Gueguen; Arnaud Chevrollier; Isabelle Maystadt
Journal:  Front Neurol       Date:  2022-09-23       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.